You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (7)

Journals (0)

1-7 of 7 results for C797S

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib

Open access

Case report

First published 2020-6

Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib

Xiaohui Ren, Xinfeng Cai, Jing Li [...]

Journal of International Medical Research

Select article: A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Open access

Case report

First published 2025

A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Xiaopeng Meng, Jingyi Liu, Xiaohui Wu [...]

Sage Open Medical Case Reports

Select article: BLU-945,a potent and selective next-generation EGFR TKI,has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

Open access

Research article

First published 2024

BLU-945,a potent and selective next-generation EGFR TKI,has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

Sun Min Lim, Stefanie S. Schalm, Eun Ji Lee [...]

Therapeutic Advances in Medical Oncology

Select article: First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness,Resistance Mechanisms,and Prognosis of Different Subsequent Treatments

Open access

Research article

First published 2022

First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness,Resistance Mechanisms,and Prognosis of Different Subsequent Treatments

Naifu Nie, Jianghua Li, Jian Zhang [...]

Clinical Medicine Insights: Oncology

Select article: Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Open access

Research article

First published 2022

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Sun Min Lim, San-Duk Yang, Sangbin Lim [...]

Therapeutic Advances in Medical Oncology

Select article: Utility of Circulating Tumor DNA Assay in Identifying Mutations and Guiding Matched Targeted Therapy in Lung Cancers

Open access

Research article

First published 2024

Utility of Circulating Tumor DNA Assay in Identifying Mutations and Guiding Matched Targeted Therapy in Lung Cancers

Kun Li, Nana Zhang, Bing Xu [...]

Clinical Medicine Insights: Oncology

Select article: Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Retricted access

Review article

First published 2017-7

Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Claudia Proto, Giuseppe Lo Russo, Giulia Corrao [...]

Tumori Journal

1
10 / page

Article type

Publication date

Subjects

Access